abrdn Healthcare Opportunities Fund - SHS (THQ) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2014 to Q4 2025

Type / Class
Equity / SHS
Symbol
THQ on NYSE
Price per share
$19.13
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
7,701,858
Total reported value
$133,246,186
% of total 13F portfolios
0%
Share change
-773,797
Value change
-$14,499,777
Number of holders
105
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

As of 30 Sep 2025, 105 institutional investors reported holding 7,701,858 shares of abrdn Healthcare Opportunities Fund - SHS (THQ).

Institutional Holders of abrdn Healthcare Opportunities Fund - SHS (THQ) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 305,167 $5,860,402 +$1,224,788 $19.13 14
2025 Q3 7,701,858 $133,246,186 -$14,499,777 $17.29 105
2025 Q2 8,439,330 $155,179,325 -$1,024,056 $18.39 98
2025 Q1 8,437,703 $174,135,760 +$7,926,744 $20.64 93
2024 Q4 8,229,276 $155,613,361 -$948,381 $18.87 105
2024 Q3 8,258,510 $182,047,091 -$5,615,679 $22.08 103
2024 Q2 8,553,718 $174,176,399 -$18,483,358 $20.38 96
2024 Q1 9,328,157 $187,258,445 -$24,553,132 $20.10 93
2023 Q4 10,647,001 $192,823,846 +$25,661,448 $18.11 98
2023 Q3 9,176,095 $155,810,245 +$8,608,859 $16.98 91
2023 Q2 8,643,030 $164,816,590 +$2,805,836 $19.07 78
2023 Q1 8,500,488 $159,488,973 -$2,387,400 $18.76 89
2022 Q4 8,602,876 $170,419,448 +$6,068,470 $19.81 85
2022 Q3 8,297,744 $150,388,503 +$4,669,533 $18.12 78
2022 Q2 8,039,552 $160,310,094 -$1,615,464 $19.94 83
2022 Q1 8,105,159 $180,351,380 +$1,840,752 $22.26 92
2021 Q4 7,989,562 $204,858,448 -$3,961,463 $25.64 90
2021 Q3 8,098,781 $183,472,855 +$3,443,833 $22.65 79
2021 Q2 7,942,792 $183,505,085 -$3,330,241 $23.10 76
2021 Q1 8,001,015 $173,847,350 -$4,173,848 $21.73 71
2020 Q4 8,190,211 $166,803,095 -$1,905,417 $20.38 66
2020 Q3 8,273,826 $149,584,523 -$2,083,012 $18.09 64
2020 Q2 8,354,717 $148,603,450 +$8,701,587 $17.80 67
2020 Q1 7,715,908 $118,479,128 -$17,515,655 $15.36 77
2019 Q4 8,561,403 $163,258,000 +$4,881,050 $19.07 65
2019 Q3 7,999,035 $139,611,111 +$149,367 $17.46 58
2019 Q2 7,976,471 $142,103,237 -$6,448,765 $17.82 60
2019 Q1 8,651,600 $152,356,167 -$4,326,753 $17.62 64
2018 Q4 8,898,907 $149,301,873 -$1,325,860 $16.78 59
2018 Q3 8,919,595 $167,161,849 +$7,642,059 $18.74 69
2018 Q2 8,527,975 $146,056,633 +$7,778,558 $17.04 70
2018 Q1 8,060,492 $132,954,284 +$7,966,705 $16.48 63
2017 Q4 7,558,349 $132,423,236 -$907,100 $17.52 66
2017 Q3 7,584,736 $140,854,000 +$8,328,017 $18.57 57
2017 Q2 7,138,272 $130,915,000 +$7,255,452 $18.34 52
2017 Q1 6,748,998 $117,373,000 -$4,969,603 $17.40 53
2016 Q4 7,038,505 $110,139,000 +$7,665,887 $15.52 54
2016 Q3 6,563,640 $114,732,000 +$8,362,450 $17.48 48
2016 Q2 6,198,267 $103,113,497 +$3,860,783 $16.63 52
2016 Q1 5,416,162 $86,208,345 -$2,414,674 $15.91 40
2015 Q4 6,044,798 $105,097,000 +$13,570,935 $17.39 45
2015 Q3 5,253,133 $85,669,000 +$9,733,306 $16.30 41
2015 Q2 4,634,759 $91,830,081 +$14,358,838 $19.83 30
2015 Q1 3,909,164 $80,036,676 +$19,267,010 $20.58 26
2014 Q4 2,955,026 $59,241,115 +$34,789,198 $20.05 19
2014 Q3 1,128,902 $21,280,000 +$21,280,000 $18.85 14